Find Funding
Below are funding resources from the National Institutes of Health (NIH), the UCLA Health Jonsson Comprehensive Cancer Center and UCLA. For more information on UCLA Health JCCC-related funding opportunities, please visit our Internal Funding and External Funding pages.
NIH Funding Resources
NIH Grants and Funding Search Guide
UCLA Health Jonsson Comprehensive Cancer Center Funding Resources
Extramural Quarterly Funding Announcement
The UCLA Health JCCC provides an Extramural Quarterly Funding Announcement for UCLA investigators. This includes currently open extramural funding opportunities that are of interest to UCLA investigators. it is emailed directly to members.
Extramural Limited Submission Funding Opportunities
Limited extramural funding opportunities are provided below as a courtesy to UCLA Health JCCC members. For an opportunity to be included on this list, it must be a cancer-relevant Limited Submission Opportunity (LSO). LSOs for NIH Administrative Supplements responsive to the UCLA Health JCCC’s Support Grant, P30CA016042, are also included on this list. Submission instructions are noted below.
For more information, please visit our online funding portal, InfoReady. Here, you can find detailed information about available LSOs and explore the home page for more opportunities. If you have any questions about specific LSOs listed below or about NIH Administrative Supplements (under UCLA Health JCCC’s Support Grant, P30CA016042), please contact Sarah Anwar Tar via email.
NCI Administrative Supplements to P30 Cancer Center Support Grants for Clinical Testing of Cell-based Immunotherapies in Pediatric Solid Tumors (Can-ACT)
The National Cancer Institute (NCI) announces an opportunity for supplemental funding to accelerate development, innovation and establishment of adoptive cellular therapy clinical trials for treatment of pediatric patients with solid tumors. The goal of these supplements is to provide funding for centers to conduct early-stage clinical trials for solid tumors in children, adolescents and young adults. The successful applicants/site will be added as an associate member to the Cancer Adoptive Cellular Therapy (Can-ACT) Network, dedicated to developing innovative cell therapy approaches for the treatment of solid tumors in pediatric and adult cancer patients.
How to apply
To submit your nomination application, please access our 2025 NCI Adminstrative Supplements grants online application via InfoReady.
Deadline
Please submit a one-page research summary and a current NIH Biosketch by Wednesday, July 2, 2025 at 5pm PST.
UCLA Funding Resources
We Want to Hear from You!
Help us improve your experience with our services! Click the Take Survey button to take a short three-question survey.